Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin

NCT02426294 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

154

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Pioglitazone
DRUG: Glimepiride

Sponsor

Pusan National University Hospital